Abdominal mesothelioma survivor Jessica Blackford-Cleeton, her husband, Brandon Cleeton, and their son, Avery.
Gaining hope and healing after a cancer diagnosis

For Jessica Blackford-Cleeton, treatment for mesothelioma included HIPEC, a targeted form of chemotherapy delivered directly into her abdomen following surgery. Her comprehensive treatment was successful, preserving her ability to become a mother.

Chicago students to get hands-on cancer research experience through $1.9 million grant to UChicago Medicine

The Chicago EYES on Cancer program will recruit students from underrepresented backgrounds and teachers from Chicago Public Schools for a two-year summer research apprenticeship. The University of Chicago Medicine Comprehensive Cancer Center received a $1.9 million grant from the National Cancer Institute to launch the program.

UChicago Medicine offering novel prevention option to women at risk for ovarian cancer

Could delaying removal of ovaries prevent or delay sexual dysfunction in women who are at high risk for developing ovarian cancer? University of Chicago Medicine researcher Iris Romero, MD, MS, launched a study with researchers at other leading institutions to answer this question.

Obesity and cancer: It keeps getting worse

Ernst Lengyel, MD, PhD, chairman of the Department of Obstetrics/Gynecology​ at UChicago Medicine, writes about the growing yet under appreciated impact of obesity on cancer.

Wider sampling of tumor tissues may guide drug choice, improve outcomes

A new study describing genetic variations in tumors could help physicians make better treatment choices for patients with gastric and esophageal cancer.